DFJ Mercury
Description
DFJ Mercury, originally established in 2005, was a prominent early-stage venture capital firm based in Houston, Texas. As part of the extensive DFJ Global Network, it leveraged the brand recognition and resources of Draper Fisher Jurvetson, a well-known name in the venture capital industry. This affiliation provided DFJ Mercury with a strong foundation and access to a broader ecosystem for deal flow and co-investment opportunities, particularly in the burgeoning technology sector. The firm's initial focus was primarily on seed-stage investments, aiming to identify and support promising startups in their earliest phases of development.
Over time, DFJ Mercury evolved and is now known as Mercury Fund, maintaining its core mission of investing in enterprise technology companies. The firm targets businesses specializing in areas such as enterprise SaaS, cloud computing, data analytics, artificial intelligence/machine learning, and cybersecurity. Mercury Fund typically leads or co-leads seed and Series A funding rounds, demonstrating a commitment to being a significant partner in their portfolio companies' growth. Their initial investment checks generally range from $1 million to $5 million, providing substantial capital for early-stage development and market penetration.
Mercury Fund has grown significantly since its inception, now managing over $500 million in capital across multiple funds. This substantial capital base enables them to support their portfolio companies through follow-on rounds and strategic guidance. With a track record of over 100 investments, the firm has established itself as a key player in the early-stage tech ecosystem, particularly within the Texas triangle (Houston, Austin, Dallas) and extending into the Midwest and Mid-Atlantic regions. Their strategy emphasizes deep engagement with founders, offering operational expertise and network connections to accelerate growth and achieve successful outcomes.
Investor Profile
DFJ Mercury has backed more than 75 startups, with 0 new investments in the last 12 months alone. The firm has led 22 rounds, about 29% of its total and boasts 11 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Debt Financing, Series B rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Health Care, Medical.
- Typical check size: $1M – $5M.
Stage Focus
- Series A (28%)
- Debt Financing (27%)
- Series B (17%)
- Series Unknown (9%)
- Series C (9%)
- Seed (4%)
- Series F (1%)
- Series D (1%)
- Convertible Note (1%)
- Series E (1%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Software
- Manufacturing
- Saas
- Information Technology
- Enterprise Software
- Life Science
- Advertising
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.